Mr. Shaheen Shamsavari serves as Director of Venture Investments and Business Development at Xandex Ventures. He joined Xandex Inc., in 2007 and has been responsible for Business Development in Xandex's Semiconductor, Solar, and Investment Divisions. He has international business development expertise in South East Asia and Japan and is currently focusing his efforts on managing Xandex Investments' portfolio. Since 2007, he has been a member and active investor at the Life Science Angels, Keiretsu Forum, North Bay Angels and HealthTech Capital. Prior to his work at Xandex, he worked at Gilead Sciences in Formulations and Process Development and focused on the preclinical development of HIV and Hepatitis C therapeutics. He is a graduate of the University of California at Berkeley in Molecular and Cell Biology (B.S.) with a Neurobiology emphasis. He is the Founding member at HealthTech Capital. He is also an Angel Investor.